Citadel Advisors
ACOR

Citadel Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Hold
0
6801
2023
Q1
Hold
0
6905
2022
Q4
Hold
0
7008
2022
Q3
Hold
0
7044
2022
Q2
Hold
0
7286
2022
Q1
Sell
-14,455
Closed -$35K 7467
2021
Q4
$35K Buy
+14,455
New +$35K ﹤0.01% 6237
2021
Q3
Sell
-44,666
Closed -$213K 7359
2021
Q2
$213K Buy
+44,666
New +$213K ﹤0.01% 5523
2021
Q1
Hold
0
6978
2020
Q4
Sell
-132,668
Closed -$68K 5779
2020
Q3
$68K Buy
132,668
+116,048
+698% +$59.5K ﹤0.01% 4336
2020
Q2
$12K Sell
16,620
-87,805
-84% -$63.4K ﹤0.01% 4531
2020
Q1
$97K Buy
104,425
+46,641
+81% +$43.3K ﹤0.01% 4369
2019
Q4
$118K Buy
+57,784
New +$118K ﹤0.01% 4260
2019
Q3
Sell
-379,673
Closed -$2.91M 5271
2019
Q2
$2.91M Buy
379,673
+9,070
+2% +$69.6K ﹤0.01% 2108
2019
Q1
$4.93M Buy
370,603
+105,161
+40% +$1.4M ﹤0.01% 1595
2018
Q4
$4.14M Buy
+265,442
New +$4.14M ﹤0.01% 1622
2018
Q3
Hold
0
4860
2018
Q2
Hold
0
4698
2018
Q1
Hold
0
4539
2017
Q4
Sell
-13,107
Closed -$310K 4393
2017
Q3
$310K Sell
13,107
-925,587
-99% -$21.9M ﹤0.01% 2977
2017
Q2
$18.5M Buy
938,694
+614,722
+190% +$12.1M 0.02% 626
2017
Q1
$6.8M Buy
323,972
+284,793
+727% +$5.98M 0.01% 1063
2016
Q4
$737K Sell
39,179
-545,226
-93% -$10.3M ﹤0.01% 2193
2016
Q3
$12.2M Buy
584,405
+460,894
+373% +$9.62M 0.01% 681
2016
Q2
$3.15M Buy
123,511
+98,965
+403% +$2.52M ﹤0.01% 1237
2016
Q1
$649K Buy
24,546
+20,854
+565% +$551K ﹤0.01% 2064
2015
Q4
$158K Sell
3,692
-13,302
-78% -$569K ﹤0.01% 3065
2015
Q3
$450K Buy
+16,994
New +$450K ﹤0.01% 2678
2015
Q2
Sell
-19,144
Closed -$638K 4223
2015
Q1
$638K Buy
19,144
+4,798
+33% +$160K ﹤0.01% 2469
2014
Q4
$586K Sell
14,346
-90,663
-86% -$3.7M ﹤0.01% 2457
2014
Q3
$3.56M Sell
105,009
-673,029
-87% -$22.8M ﹤0.01% 1318
2014
Q2
$26.2M Buy
778,038
+565,517
+266% +$19.1M 0.03% 469
2014
Q1
$8.06M Sell
212,521
-89,813
-30% -$3.4M 0.01% 900
2013
Q4
$8.83M Buy
302,334
+200,547
+197% +$5.86M 0.01% 816
2013
Q3
$3.49M Buy
101,787
+50,160
+97% +$1.72M 0.01% 1063
2013
Q2
$1.7M Buy
+51,627
New +$1.7M ﹤0.01% 1465